v3.26.1
Warrant Liabilities
3 Months Ended
Mar. 31, 2026
Warrant Liabilities [Abstract]  
Warrant liabilities
8.Warrant liabilities

 

The Corporation has warrants classified as financial liabilities as they are not considered to be indexed to the common shares of the Corporation, due to the exercise price of the warrants denominated in a currency other than the Corporation’s functional currency. In addition, during the three months ended March 31, 2026, the Corporation issued a warrant in respect of 269,231 SV Shares that do not meet the criteria for equity classification because they include provisions that could require the Corporation to redeem the warrants for cash upon expiration if specified market conditions are not met, resulting in a potential obligation to transfer cash that is outside the Corporation’s control. Therefore the Corporation records these warrants as financial liabilities measured at fair value upon initial recognition. At each subsequent reporting date, the warrants are re-measured at fair value and the change in fair value is recognized through profit or loss. Upon warrant exercise, the fair value previously recognized in warrant liabilities is transferred from warrant liabilities to additional paid-in capital.

The following table summarizes the changes in the warrant liabilities for the Corporation’s warrants for the periods ended March 31, 2026 and December 31, 2025:

 

   Number of
warrants
   Amount 
Balance, December 31, 2024   3,636,363   $3,040,494 
Warrants issued   1,492,190    3,215,255 
Warrants exercised   (3,653,410)   (7,324,588)
Revaluation of warrant liabilities   
-
    3,110,015 
Foreign currency translation   
-
    256,754 
Balance, March 31, 2025   
 
    
 
 
Balance, December 31, 2025   1,475,143    2,297,930 
Warrants issued   269,231    599,039 
Revaluation of warrant liabilities   
-
    (784,833)
Foreign currency translation   
-
    (35,376)
Balance, March 31, 2026   1,744,374   $2,076,760 

 

The fair value of the Corporation’s warrants issued during the three months ended March 31, 2026 were determined using the Monte Carlo simulation model with the following assumptions: expected life of 5 years; risk-free rate of 3.65%; expected volatility of 120.57%; and dividend yield of 0%. As at March 31, 2026, the warrants were remeasured with the following assumptions: expected life of 4.9 years; risk free rate of 3.92%; expected volatility of 113.16%; and dividend yield of 0%. The Corporation determined the fair value of the warrant liability based on based on Geometric Brownian Motion, which reflected our estimates regarding the probability and timing of events that could result in payments to the warrant holder or the exercise of the warrants.

 

The fair value of the Corporation’s warrants determined using the Black-Scholes pricing model was determined with the following weighted average assumptions:

 

   As at
March 31,
2026
   As at
December 31,
2025
 
Spot price (in CAD$)  $2.63   $3.50 
Risk-free interest rate   2.86%   2.64%
Expected annual volatility   122%   121%
Expected life (years)   2.26    2.48 
Dividend   nil    nil 

 

The following table reflects the Corporation’s warrants classified as liabilities outstanding and exercisable as at March 31, 2026.

 

Expiry date

 

SV Shares underlying

Warrants
outstanding
and
exercisable
   Exercise price 
August 15, 2027   522,727   US$2.00 
February 7, 2028   712,031   US$3.66 
July 21, 2030   240,385   US$3.59 
February 20, 2031   269,231   US$2.85 
    1,744,374